(Q37958678)

25 August 2017

title

Tyrosine kinase inhibitor-induced hypothyroidism: incidence, etiology, and management (English)

1 reference

25 August 2017

Rebecca L Brown

1

1 reference

25 August 2017

publication date

19 November 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

6

1 reference

25 August 2017

issue

4

1 reference

25 August 2017

page(s)

217-226

1 reference

https://scigraph.springernature.com/pub.10.1007/s11523-011-0197-2

25 August 2017

exact match

0 references

cites work

Sunitinib induces hypothyroidism in advanced cancer patients and may inhibit thyroid peroxidase activity

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

The clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

Imatinib induces hypothyroidism in patients receiving levothyroxine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

Lack of imatinib-induced thyroid dysfunction in a cohort of non-thyroidectomized patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

Beneficial effects of combining nilotinib and imatinib in preclinical models of BCR-ABL+ leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

Extended kinase profile and properties of the protein kinase inhibitor nilotinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

Thyroid dysfunction caused by second-generation tyrosine kinase inhibitors in Philadelphia chromosome-positive chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

Motesanib diphosphate in progressive differentiated thyroid cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

Vandetanib (100 mg) in patients with locally advanced or metastatic hereditary medullary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

21 January 2018

Axitinib (AG-013736).

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

Clinical characteristics of thyroid abnormalities induced by sunitinib treatment in Japanese patients with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

Thyrotoxicosis during sunitinib treatment for renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

Sunitinib-induced thyrotoxicosis followed by persistent hypothyroidism with shrinkage of thyroid volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

Shrinkage of thyroid volume in sunitinib-treated patients with renal-cell carcinoma: a potential marker of irreversible thyroid dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

Iodide inhibits vascular endothelial growth factor-A expression in cultured human thyroid follicles: a microarray search for effects of thyrotropin and iodide on angiogenesis factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

Thyrotropin (TSH)-induced production of vascular endothelial growth factor in thyroid cancer cells in vitro: evaluation of TSH signal transduction and of angiogenesis-stimulating growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

Effect of sunitinib on growth and function of FRTL-5 thyroid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

Sunitinib-associated lymphocytic thyroiditis without circulating antithyroid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

Tyrosine kinase inhibitors and modifications of thyroid function tests: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

TSH-activated signaling pathways in thyroid tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

Selective modulation of protein kinase A I and II reveals distinct roles in thyroid cell gene expression and growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

Hypothyroidism related to tyrosine kinase inhibitors: an emerging toxic effect of targeted therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

Unanswered questions regarding the management of sunitinib-induced hypothyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

Subclinical Hypothyroidism: An Update for Primary Care Physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

Influence of L-thyroxine administration on poor-platelet plasma VEGF concentrations in patients with induced short-term hypothyroidism, monitored for thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-011-0197-2

Propylthiouracil-induced hypothyroidism reduces xenograft tumor growth in athymic nude mice

21 January 2018

1 reference

12 December 2020

Effects of hypothyroidism on the induction and growth of mammary cancer induced by 7,12-dimethylbenz(a)anthracene in the rat

1 reference

12 December 2020

Re: Hypothyroidism in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib

1 reference

12 December 2020

Management of axitinib (AG-013736)-induced fatigue and thyroid dysfunction, and predictive biomarkers of axitinib exposure: results from phase I studies in Japanese patients.

1 reference

12 December 2020

Hypothyroidism in patients with renal cell carcinoma: blessing or curse?

1 reference

12 December 2020

Vascular endothelial growth factor (VEGF), VEGF receptors expression and microvascular density in benign and malignant thyroid diseases

1 reference

12 December 2020

A Novel Tyrosine-Kinase Selective Inhibitor, Sunitinib, Induces Transient Hypothyroidism by Blocking Iodine Uptake

1 reference

12 December 2020

Combining radiotherapy with AZD2171, a potent inhibitor of vascular endothelial growth factor signaling: pathophysiologic effects and therapeutic benefit

1 reference

12 December 2020

Hypothyroidism correlates with a better prognosis in metastatic renal cancer patients treated with sorafenib or sunitinib.

1 reference

12 December 2020

Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial

1 reference

12 December 2020

Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib

1 reference

12 December 2020

Propylthiouracil-induced chemical hypothyroidism with high-dose tamoxifen prolongs survival in recurrent high grade glioma: a phase I/II study.

1 reference

12 December 2020

Association between development of hypothyroidism and improved survival in patients with head and neck cancer

1 reference

12 December 2020

Nilotinib-induced hypothyroidism in a patient with chronic myeloid leukemia

1 reference

12 December 2020

A phase II trial of imatinib therapy for metastatic medullary thyroid carcinoma

1 reference

12 December 2020

10.1007/S11523-011-0197-2

Identifiers

DOI

1 reference

25 August 2017

1 reference